Talis Biomedical's ROI from its second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Talis Biomedical's ROI in the second quarter of 2024?
Talis Biomedical Corporation recorded a cumulative net loss of $-51 million during 12 months ending in the second quarter of 2024, resulting in a negative return on investment (ROI) of -63.35%.

Within the Healthcare sector 597 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2024 from 0 to 3749.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter
Y / Y Investment Change TTM	-43.97 %	-44.47 %	-44.86 %	-42.4 %	-38.93 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	65	73	86	99	114
Return On Investment (TTM)	-63.35 %	-61.6 %	-59 %	-61.48 %	-59.7 %
TLIS's Overall Ranking	# 3749	# 0	# 0	# 4057	# 4216
Seq. Investment Change TTM	-13.27 %	-11.62 %	-14.4 %	-14.6 %	-14.05 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-51	-57	-62	-75	-86

TLIS Company Profile >> Back to TLIS Roi Comparisons >> See Annual TLIS Return On Investment

Return On Investment TLIS's Ranking
Within:	No.
Industry	# 22
Sector	# 598
Overall	# 3749

Return On Investment Statistics
High	Average	Low
-53.83 %	-60.57 %	-67.91 %
(Sep 30 2022)		(Mar 31 2021)

Financial Statements
Talis Biomedical's II. Quarter Investments	$ 65 Millions	TLIS's Balance sheet
Talis Biomedical's II. Quarter Income	$ -9 Millions	Quarterly TLIS's Income Statement
TLIS's Income by Division		See TLIS's Income by Division

TLIS Annual Return On Investment	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	86	157	247	0	0
Y / Y Investment Growth	-45.15 %	-36.52 %	-	-	-
Net Income in Millions	-62	-113	-192	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-72.18 %	-72.16 %	-77.83 %	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TLIS's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TLIS's Competitors
Subscribers only: Roi for Talis Biomedical's Suppliers
Subscribers only: Return On Investment for TLIS's Customers

Other Ratios
TLIS's Roa	TLIS's Inventory Turnover Ratio	TLIS's Growth Rates	TLIS's Dividend Statistics
	TLIS's Profitability Ratios	TLIS's Asset Turnover Ratio	TLIS's Dividend Growth
TLIS's Roe	TLIS's Valuation Ratios	TLIS's Financial Strength Ratios	TLIS's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2024, within Healthcare Sector

ROI

Date modified: 2026-08-29T17:43:13+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.